Vendor description
This vendor hasn't published their own description yet. It will appear here once they claim this profile and add it from their dashboard.
At a glance
- PathAI applies AI-powered pathology to clinical trials,improving diagnostic accuracy and biomarker detection for oncology and other therapeutic areas.
- Coverage: Global · Phase I–III
- Therapeutic focus: Oncology, Pathology
- Scale: Small,Medium
Company fit
Best suited for
Oncology trials needing AI-driven pathology and biomarker analysis
Study fit
Best suited for oncology trials needing ai-driven pathology and biomarker analysis.
Core strengths
- AI-powered digital pathology
- Biomarker quantification
- Oncology focus
Considerations
- Pathology-specific,not full-service
- Emerging clinical trial adoption
Key facts
- Category
- AI / Machine Learning
- Geography
- Global
- Studies managed
- 45
- HQ
- United States